Home Blog Page 295

SENTA Expands Offering with South Carolina ENT, Adding Ambulatory Surgical Center

0
SENTA Expands Offering with South Carolina ENT, Adding Ambulatory Surgical Center
The only dedicated ENT surgical center in the Columbia, SC, market

Today, SENTA ("Southern Ear, Nose, Throat and Allergy Physicians") proudly announces that South Carolina ENT, Allergy & Sleep Medicine ("SCENT") is expanding to include a new 21,000-sq.-ft. flagship building, housing a 14-exam room clinic, a six-days-a-week walk-in clinic, and a state-of-the-art ambulatory surgical center (ASC). This innovative, patient-centered facility will specialize in providing high-quality, compassionate care in an outpatient and ambulatory setting. SENTA Partners is backed by Shore Capital Partners and is committed to partnering with leading physicians to build a premier network of ENT and allergy services in the U.S.

"SCENT Surgical Center will be the only surgical center in Columbia exclusively specializing in ENT surgical procedures. This center will enable us to provide the very latest in quality care to our patients throughout South Carolina," said Robert Puchalski, M.D., medical director. "SENTA's unparalleled support and expertise have allowed us to accelerate our growth in the marketplace; I can't wait to see the positive impact this new offering will have on physician recruitment, the efficiency of care, savings for our commercially-insured patients, and most importantly, the overall health of our local community." 

SCENT Ambulatory Surgical Center in South Carolina has a highly trained professional staff committed to providing patients with the best care and treatments possible. It is the second-largest privately-owned ENT and Allergy practice in the state. The surgeons at SCENT Surgical Center are board-certified and specialize in a wide spectrum of ENT surgical procedures. SCENT physicians also partner with the University of South Carolina School of Medicine, providing elective rotations for residents and medical students. SCENT physicians also take a leading role in the medical community by partnering with MUSC and PRISMA to provide consultative on-call services for inpatients and emergency department patients.

"Partnering with our practices to understand and identify what's needed in their community is key to success both to accelerate our treatment capabilities and grow the business," said Adam Low, CEO, SENTA. "Identifying best practices and scaling them, such as the addition of the ASC in the South Carolina market, along with exceptional quality patient care, is a cornerstone for SENTA and this further delivers on our mission." 

If interested in learning more about a partnership with SENTA, contact the Chief Development Officer, Zack Usilton, at [email protected] 

ABOUT SENTA PARTNERS

Southern Ear, Nose, Throat and Allergy Physicians (SENTA) is a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region. SENTA provides the highest quality allergy, asthma, immunology, and otolaryngology care leading to better patient outcomes. Founded in 2019 with an investment from Shore Capital Partners, SENTA provides strategic, operational, and administrative support to our ENT partner practices and allergy, empowering physicians to focus on their patients. For additional information on SENTA, please visit www.SENTAPARTNERS.com. 

Contact Information:
Andrea Morgan
PR
[email protected]
9172135506


Original Source: SENTA Expands Offering with South Carolina ENT, Adding Ambulatory Surgical Center

Intend Announces Strategic Partnership With Mobility Health

0
Intend Announces Strategic Partnership With Mobility Health
Integrating Intend's Patient Management Platform with Mobility Health's Laboratory and Medical Billing Services


Intend Logo

Intend, Inc. Logo

Intend, Inc., a patient-centric healthcare management software provider, today announced a strategic partnership with Mobility Health, a Mason, Ohio-based biohealth diagnostic company that pushes the boundaries of innovation in molecular science to provide accurate, rapid testing of infectious diseases to pharmacies nationwide. This landmark partnership provides pharmacies and other medical service providers with a Mobility Health branded version of the Intend Platform featuring real-time integration with laboratory testing and medical billing services.

Under this Value-Added Reseller (VAR) partnership, Mobility Health will offer a custom-branded version of the Intend Platform to their over 200 independent pharmacy clients and potentially thousands of pharmacies nationwide.

This powerful platform, strengthened by Mobility Health's expert diagnostic testing, will provide pharmacies and other medical service providers with comprehensive, seamless solutions designed to streamline medical service delivery processes from marketing to medical billing and everything in between.

"Intend, Inc. has always aimed to create technology that transforms and streamlines healthcare delivery," said Eric Kupferberg, President of Intend, Inc. "This partnership with Mobility Health will further extend the capabilities of our platform, opening new avenues of service delivery and leading to significant improvements in the medical care provided by pharmacies and medical providers nationwide."

Sandra Gunselman, Ph.D., Founder, President & CEO of Mobility Health, shared, "We're delighted to enter the partnership with Intend offering us an opportunity to leverage their industry-leading platform to provide the pharmacy a complete end-to-end provider services solution. Intend allows us to extend the capabilities of our laboratory and billing service offering to existing and new pharmacy clients, all while extending our mission of decentralizing lab services and enabling wider, more equitable access to diagnostics that can improve lives."

About Mobility Health

Mobility Health is a biohealth diagnostic company focused on providing accurate, rapid testing of infectious diseases to protect population health and safety. Mobility Health was established with a mission to transform community-based healthcare by deploying new technologies that eliminate barriers to rapid, advanced molecular testing and healthcare services. Founded in 2020 by Sandra Gunselman, Ph.D., a molecular biologist, and laboratory operations expert with a passion for reaching patients in need, the company is an integral member of the Mason Tech Elevator, which serves as a living lab for corporate collaboration, mentoring, and entrepreneurship to spur novel bioscience and technology innovations. For more information, visit http://www.mobilityhealthlab.com.

About Intend

Intend delivers marketing campaign management, medical service scheduling, insurance verification, ePrescriptions, billing, reporting, and patient communication to healthcare providers nationwide. Since 2020, the Intend software platform has processed over 5.5 million medical procedures across more than 5,000 client accounts, serving millions of patients. The company's customizable SaaS solutions focus on:

  • Marketing campaign automation via email, text and internet advertising
  • Online appointment scheduling with patient and client account portals
  • Automated insurance verification and medical billing integration
  • ePrescription writing and integration with the SureScripts Network
  • Flexible integrations with laboratories and state government agencies

Intend partners with pharmacies, urgent care providers, physician offices, and laboratories to enhance business function while delivering superior patient care.

For more information or to schedule a demo, visit https://demo.intend.io.

Contact Information:
Public Relations
[email protected]
844-468-3631


Original Source: Intend Announces Strategic Partnership With Mobility Health

Dr. Mark Denker of Palm Beach Fertility Center to Present at Reproductive Health Conference in Dubai, UAE

0
Dr. Mark Denker of Palm Beach Fertility Center to Present at Reproductive Health Conference in Dubai, UAE
Presentation to Focus on Estrogen Androgen Priming Protocol Improving IVF Response

Dr. Mark Denker, a renowned board-certified obstetrician/gynecologist who founded the Palm Beach Fertility Center, has been selected to present at the 8th International Conference on Reproductive Health, Embryology and Fertility, taking place July 10-11, 2023, in Dubai, UAE. Dr. Denker's presentation will focus on his clinical trial that proves an estrogen androgen priming protocol dramatically improves response to gonadotropins in IVF cycles.

The reproductive health conference featuring Dr. Denker serves as a global platform for world-leading gynecologists and other healthcare professionals to exchange knowledge on reproductive health and educate one another about cutting-edge research studies and findings. The two-day event features discussions, keynote presentations, poster presentations, exhibitions, symposiums, workshops and a young researcher's forum.

Dr. Denker's session will detail his years of optimizing IVF protocols for older women and poor responders. His research leveraged earlier findings that priming the ovaries with estrogen prior to an IVF cycle is highly beneficial, as well as androgen priming. His study questioned if treatment would be more effective if the two hormones were combined, which led to his clinical trial with poor responder patients who had been canceled in a previous IVF cycle or had done poorly. They were treated with an estrogen and androgen priming protocol, which resulted in a 40 percent pregnancy rate in trial participants.

Dr. Denker has garnered international attention for his best-in-class care offered at the Palm Beach Fertility Center, which he founded to offer personalized and affordable reproductive healthcare. Due to his efforts, more than 5,000 babies have been born through effective fertility treatments—many of whom were born to women with a history of failed treatments or older women with decreased ovarian reserve. Dr. Denker earned his medical degree from Baylor College of Medicine in Houston, Texas, after which he completed his residency in Obstetrics and Gynecology at the University of Miami/Jackson Memorial Hospital. In addition, he completed a fellowship in Reproductive Endocrinology at the University of California Irvine. He is the recipient of the Pacific Coast Fertility Society prize paper, University of California Research Symposium Award, and a President's Undergraduate Research Fellowship.

To learn more about the 8th International Conference on Reproductive Health, Embryology and Fertility, visit https://reproductivehealth.conferenceseries.com.

Additional information about Dr. Denker's fertility practice is available online at https://www.palmbeachfertility.com.

Contact Information:
Ksenia Gruenberg
Marketing Manager
[email protected]


Original Source: Dr. Mark Denker of Palm Beach Fertility Center to Present at Reproductive Health Conference in Dubai, UAE

Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas

0
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas

iLet Dexcom G6

iLet with Dexcom G6

  • Now the iLet Bionic Pancreas is cleared for three insulins
  • More insulin choices for users
  • Prefilled insulin cartridge saves time and provides convenience for users

Beta Bionics, Inc. — a medical technology company focused on diabetes — announces FDA 510(k) clearance for compatibility with the Fiasp® Pumpcart® (insulin aspart) prefilled insulin cartridge. The iLet is the first and only automated insulin-delivery system that does not require carb counting, fully automates 100% of all user insulin doses, and will provide users the choice of three insulins - Novolog®, Humalog® and Fiasp® Pumpcart®

"Beta Bionics has been working tirelessly to create an insulin delivery system that offers less burden and more convenience for the type 1 community. Since launching last month in May 2023, the iLet Bionic Pancreas is now available and clinics and users are being trained on its simple design and easy management features," said Sean Saint, President and CEO of Beta Bionics. "When Fiasp® Pumpcart® prefilled cartridges are available, users will save time not having to manually fill cartridges and will have more choice for their diabetes management."

The iLet was designed to alleviate the work of diabetes management in everyday life and nearly eliminate the expertise that has been required to set up and manage a traditional insulin pump. The only input that is required to get started is the user's weight. No carb counting*, bolusing, correction factors, insulin-to-carb ratios, or pre-set basal rates - the iLet manages a user's glucose levels with just a meal announcement and it does the rest of the work. The iLet is paired with a Dexcom G6 Continuous Glucose Monitoring System for glucose readings.

If you'd like to GO BIONIC with the iLet Bionic Pancreas, visit our website to fill out a form to get started - www.betabionics.com

*Carb awareness is required. 

Fiasp® Pumpcart®, Humalog® and Novolog® are registered trademarks of Novo Nordisk A/S. Fiasp® Pumpcart® not yet available for sale in the US. 

Contact Information:
Stephen Feider
Chief Financial Officer & Corporate Secretary
[email protected]

Karen Hynes
Vice President of Marketing
[email protected]


Original Source: Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas

EcoClear Partners With the City of St. Petersburg to Minimize Pests

0
EcoClear Partners With the City of St. Petersburg to Minimize Pests
EcoClear's RatX® is poison-free and only affects target species, improving the quality of life in the area.

EcoClear Products, Inc., a leading manufacturer of safe, eco-friendly pesticides, announces an agreement with the City of St. Petersburg, Florida's Sanitation Department. The city will use EcoClear's RatX® as a city-wide rodent control solution, in order to safely resolve the common problem of rodent overpopulation without affecting people, their pets, and the local wildlife. 

"The residents of St. Petersburg are living in a city that cares about its people, pets, and wildlife," Christopher Stidd, President of Ecoclear Products, said. "The city's choice to use EcoClear's effective and poison-free method of extermination sets the city and its citizens ahead of the curve." 

RatX ® is an all-natural product with two active ingredients, corn gluten meal and sodium chloride, safe to use around people and pets, with no risk of secondary kill to non-target species like birds of prey or wildlife. It reduces the smell of dead rodent carcasses by up to 90% while also providing a more cost-effective solution than poisons and private extermination contractors. 

"Using RatX® will save the taxpayers money, as the city no longer has to use outside services to control rodents," Stidd said. "The city is choosing a sustainable way to get rid of unwanted pests like rats and mice, while at the same time protecting the health and safety of people and non-target animals." 

RatX® Pellets are effective for indoor and outdoor rat and mouse control when used as directed and are safe to use around landscaping, near livestock housing, or under buildings or garden structures.   

EcoClear's rodenticides are made with ingredients that meet the Food & Drug Administration's GRAS (Generally Recognized as Safe) standard. They target only the specific, intended species, so non-target animals such as pets, wildlife, and birds are safe from harm. 

For more information, please visit www.ecoclearproducts.com/pro.  

About EcoClear Products 

EcoClear Products, Inc. is a leading developer of specialty products, which include ecological cleaning, odor removal products, and pest control solutions. Based in Sarasota, Florida, and founded in 2013, EcoClear's mission is to develop innovative and effective products safe for people, pets, and wildlife. EcoClear has been recognized for its commitment to advancements in sustainable chemistry and efficacy. For more information, visit www.ecoclearproducts.com/pro

Contact Information:
Maria Penaloza
[email protected]


Original Source: EcoClear Partners With the City of St. Petersburg to Minimize Pests

Peace Love Art: Charity Art Sale Partners Professional Athletes With Artists for Great Causes

0
Peace Love Art: Charity Art Sale Partners Professional Athletes With Artists for Great Causes
250 Artists, 11 Sports and Entertainment Celebrities, and 10 Charities join forces to promote the sale of over 700 works to support the arts and multiple charitable causes. Preview now, with the sale going live from July 9 through July 15, 2023.

The 3rd Annual Peace Love Art charity sale takes place Sunday, July 9-Saturday, July 15, 2023, featuring works by 250 international artists partnered with 10 charities to support the arts and causes. Featured artists include:

  • Canadian Artists Rachael Blakey, Jeffrey Malcolm, Luba Stoykovich
  • Cuban-born Artists Edel Alvarez, Pedro Hernandez, Alejandro Mazon, Ernesto Piloto
  • French Artist Geff Strik
  • Japanese Artist Kaoru Shibuta
  • Native Artists Ken Fury, Ramsey Kunkel, Craig Marks, Lauren Siyowin Peters, Brian Taaffe
  • Nigerian Artist Dominic Ibe Ajike
  • South African Artist Antoine de Villiers
  • Syrian Artist Randa Hijazi
  • USA Artists Christian Clayton, Obrianna Cornelius, Jay Decker, John Hall, Michael Kirst, Deborah Kolp, Steven Lester, Laura Letchinger, David Platt
  • UK Artists Bernard Gray and Cheryl Roach

"Last year's event focused on Indigenous Artists supporting Dream Catcher Foundation," said A+C Founder Rob Canton. "We were thrilled with the success of PLA: Indigenous Collective due to the dozens of artists that generously supported the Foundation and partnerships forged with several indigenous influencers. Everyone came together to promote indigenous artists and fight against murdered and missing indigenous women." Rob added, "We built on that success by joining forces with 10 charities, resulting in 250 artists and 700 works of art this year."

Eugene Brave Rock, best known for starring as "The Chief" in Wonder Woman (2017), is passionate about arts—particularly indigenous art. A Blackfoot from the Blood Tribe, which is part of the Blackfeet Confederacy, Gene recognizes the value of leveraging arts for causes, including his personal journey to preserve indigenous languages through his own Oki Language Project. "Native artists do a wonderful job preserving the culture of our various peoples," said Gene. "Leveraging arts to support the preservation of languages is an amazing use of the arts for good."

Houston Astros' World Series Champion and Gold Glove winner Kyle Tucker's charitable mission is bringing awareness to hospice care and helping support the quest to bring more affordable, quality care to those requiring it. "My family's experience when my grandfather was in hospice brought to light the important role of organizations and people that devote their lives to providing compassionate, end-of-life care for our loved ones and their families," said Kyle. "We are thrilled that many artists chose the Kyle Tucker Foundation to support through the sale of their artwork and hope people take time to see their amazing work and perhaps take home a piece or two."

These are two of the 10 charity beneficiaries of this year's Peace Love Art. Other charity ambassadors include Lance McCullers Jr., Eli Ankou, Chris Godwin, Johnny Damon, Allie LaForce, Joe Smith, and Jimmy Buffett-founded Save the Manatees Club.

Supporters and art collectors can preview the artwork now at https://PLA2023.givesmart.com and the site will be live for purchases from July 9 through July 15. All artists have generously agreed to direct half the funds raised from each sale to the partner charity of their choice.

###

About A+C Foundation:  A+C empowers athletes/artists to give using without the high costs and risks associated with creating their own 501(c)(3). Their fiscal sponsorship allows the opportunity to gain instant tax-exempt status. For more information, visit www.artsandcauses.org.

Contact Information:
Rob Canton
CEO
[email protected]
813-495-3572


Original Source: Peace Love Art: Charity Art Sale Partners Professional Athletes With Artists for Great Causes

U.S. Polo Assn. Hosts Extraordinary and Inspirational VIP Party During the 104th Edition of Pitti Immagine Uomo in Florence, Italy

0
U.S. Polo Assn. Hosts Extraordinary and Inspirational VIP Party During the 104th Edition of Pitti Immagine Uomo in Florence, Italy

Following its outstanding showing at Pitti Uomo 2024 at the Fortezza de Basso in Florence, Italy, U.S. Polo Assn., the official brand of the United States Polo Association (USPA), hosted an extraordinary VIP party celebrating "Live Authentically," an evening inspired by fashion, art, sport and music.  

The invitation-only event in the magical Giardino Torrigiani, in the heart of Florence, began with prosecco in the garden while models dressed in custom U.S. Polo Assn. outfits welcomed more than 350 guests for a candlelit dinner. The magical, private garden is known to be the location of the very first fashion show in Florence, so it was fitting for U.S. Polo Assn.'s Pitti VIP party in every way. 

As dinner concluded, U.S. Polo Assn. welcomed world-renowned Florentine artist and sculptor Antonio Signorini, who presented artwork to all guests, as well as unforgettable "horse whisperer" Santi Sierra, who left everyone speechless with his dancing horses. The event closed with one of the most popular rock bands in Europe, Planet Funk, who are on their much-buzzed-about reunion tour. Other special guests included beautiful actress and model Federica Nargi, Salvatore Ferragamo of Il Borro, Italy Polo Team Captain Stefano Giansanti, and FISE Polo's Alessandro Giachetti, among many more. 

The event was sponsored by world-renowned Il Borro wine, alongside Champagne Partner, Taittinger, and Sammontana Gelati. Last but not least, specialty Porsches with the red, white and blue U.S. Polo Assn. logo were on site, representing "horsepower," exhibited and sponsored by Centro Porsche Firenze. 

"I had a vision for this night in the beautiful Giardino Torrigiani. Our goal was to express our brand in a very special way to our guests through the collaboration of fashion, art, sports and music. We achieved this expression with great success," said Lorenzo Nencini, Incom CEO and U.S. Polo Assn.'s Italian apparel partner, who was appointed and serves on the 2023 Pitti Immagine's Board of Directors. 

The event's hosts were Nencini and J. Michael Prince, the President and CEO of USPA Global Licensing, the company that manages and oversees the $2.3 billion dollar U.S. Polo Assn. brand across 190 countries, including Italy. Alongside Prince and Nencini were U.S. Polo Assn. Italian partners Augusto Bonetto, CEO of Bonis; Andrea Zini, CEO of EastLab; and Franco Zuccon, CEO of Eurotrade.  

"The U.S. Polo Assn. Pitti VIP event was an opportunity to share our brand message to 'Live Authentically' and bring inspiration to our very special guests," said J. Michael Prince, President and CEO of USA-based USPA Global Licensing, the company that manages and oversees the U.S. Polo Assn. brand. "This was a very special night that I won't soon forget, and I imagine our guests feel the same way." 

"Lorenzo and I are grateful for the many partners, employees and sponsors that made this such an extraordinary and successful evening," Prince added. 

The VIP event followed U.S. Polo Assn.'s outstanding presentation of its vibrant, sporty Spring-Summer 2024 Collection from June 13-16 at Pitti Immagine Uomo at the iconic Fortezza da Basso in Florence, celebrating the brand's heritage in the sport of polo since 1890. The immersive experience drew crowds to the show for its authentic style as well as the special guest appearance by entrepreneur, TV presenter, Instagram influencer and sports enthusiast Federica Nargi, along with sporty models dressed as polo players walking the showroom floor.  

About U.S. Polo Assn. 

U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the non-profit governing body for the sport of polo in the United States and one of the oldest sports governing bodies, having been founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through over 1,100 U.S. Polo Assn. retail stores and thousands of department stores, sporting goods channels, independent retailers, and e-commerce, U.S. Polo Assn. offers apparel for men, women, and children, as well as accessories and footwear in more than 190 countries worldwide. U.S. Polo Assn. was named one of the top five sports licensors in 2022, alongside the NFL, MLB, and NBA, according to License Global. Visit uspoloassnglobal.com and follow @uspoloassn

About Incom S.p.A 

Incom S.p.A, founded in Montecatini Terme (PT) in 1951, manages, as a licensee, the apparel for the U.S. Polo Assn. brand in Western Europe, which produces and distributes iconic clothing brands all over the world. In addition, Incom is one of the main suppliers of military and paramilitary clothing in the Italian State both for uniforms and for technical clothing. Since January 2008, it has been producing and distributing men's, women's, and children's clothing in Western Europe under the U.S. Polo Assn. brand, with record sales results and growth. For further information, visit www.incomitaly.com

EuroTrade s.r.l. 

EuroTrade is U.S. Polo Assn.'s licensee in Western Europe for watches and accessories. Headquartered in Italy, EuroTrade was founded in 1987 and specializes in the creation and distribution of high-quality watches and accessories characterized by original design and innovative technology. EuroTrade offers the market an original and trendy accessory to wear on any occasion. Visit www.incomitaly.com/en/euro-trade-s-r-l/

About Bonis S.P.A. 

Bonis is the exclusive footwear licensee for U.S. Polo Assn. in Europe. Founded in 1970, Bonis is a leading company in the footwear business and is a partner selected by some of the most influential international brands. Located in the heart of the Asolo and Montebelluna footwear district, the home of the most important sport system brands. Bonis works with private labels, contracting and licensing. Visit www.bonis-spa.com

About Eastlab  

Eastlab is the exclusive licensee for U.S. Polo Assn. handbags in Europe. Founded in 2015, Eastlab today represents some of Italy's major players in the production and marketing of bags, footwear, accessories, and suitcases. Eastlab's targeted response to market demand and passion for the craft has allowed the company to quickly acquire great credibility in the market and gain the trust of important partners. Visit www.eastlab.it/

Contact Information:
Stacey Kovalsky
Senior Director, Global Communications
[email protected]
+001.561.790.8036

Maura Busatto
[email protected]

Laura Manfrin
[email protected]

Sara Montanelli
[email protected]

Laura Varani
[email protected]

Paola Varani
[email protected]


Original Source: U.S. Polo Assn. Hosts Extraordinary and Inspirational VIP Party During the 104th Edition of Pitti Immagine Uomo in Florence, Italy

Everything We Know About Fede Alvarez’s New Alien Movie

0
Everything We Know About Fede Alvarez’s New Alien Movie

Director Fede Alvarez’s new Alien film has been given a 2024 theatrical release date despite originally being planned for Hulu.

Director Fede Alvarez should now be in production on the new movie in the Alien franchise, a project which may or may not be called Alien: Romulus. Originally designed to debut on Hulu, Disney recently announced an August 16, 2024 theatrical release date for the movie, which bodes well for its quality. So as a filmmaker who’s known for moments of brutal, cringe-inducing violence works to bring the Xenomorphs back to our screens, we decided it was time to put together an article that keeps track of Everything We Know About Fede Alvarez’s New Alien Movie.

(WORKING?) TITLE

First, we have to address whether or not Alien: Romulus is really the movie’s title. The fact is, we don’t know. It could very well be a working title or a codename title that will end up being changed down the line. The first time we ever saw the Alien: Romulus title was on a production listing that was posted by the Film & Television Industry Alliance. That listing also said the movie would begin filming in Budapest, Hungary on February 6th… and while the production start date got pushed back to March 9th, filming is indeed taking place in Budapest, Hungary. The location information was correct, now we’ll have to wait and see if the title sticks as well. “Romulus” brings to mind two things, neither of which are likely to have any bearing on what the movie is about: Romulus was the name of the founder and first king of Rome, and it’s the name of a planet in the Star Trek universe.

Alien Romulus

YOUNG CHARACTERS IN PERIL

Alvarez put young characters through the wringer in his films Evil Dead (2013) and Don’t Breathe, and it looks like he’s going to be doing exactly the same thing in his new Alien movie. Every announced cast member in this film seems to be in their 20s (going by birthdates available online), and The Hollywood Reporter says that “as opposed to the other movies which focused on adults in corporate, militaristic and scientific roles, this now-ninth installment of the franchise will focus on a group of young people. On a distant colony, the group finds themselves in a fight for their lives with the titular alien, a creature known as a Xenomorph, whose race propagates by implanting eggs into people’s stomachs via face-huggers, with the juveniles eventually violently bursting out of the host’s chest.” Will this be the Alien equivalent of a slumber party slasher?

The cast consists of Cailee Spaeny (Mare of Easttown), David Jonsson (Industry), Archie Renaux (Shadow and Bone), Spike Fearn (The Batman), Aileen Wu (Away from Home), and Isabela Merced (Rosaline).

THE OTHER IDEAS

There were several directions the Alien franchise could have gone after the release of 2017’s Alien: Covenant. Although that film didn’t go over well with fans or critics, it did okay at the box office ($240 million worldwide) and Alien director Ridley Scott wanted to make a direct sequel. A chance to wrap up the Alien prequel trilogy he had begun with Prometheus and continued with Alien: Covenant. So that could have happened. Alternatively, the studio could have chosen to revive the Alien 5 project Neill Blomkamp had been developing, which would have brought Sigourney Weaver back as franchise heroine Ripley and given Michael Biehn’s Hicks character from Aliens a different fate than the one we had seen in Alien 3. Blomkamp’s ideas had a lot of fan support (and support from Weaver and Biehn), but it was put on ice because Scott wanted the focus to be on his prequel trilogy. Which ran into a dead end anyway. Another filmmaker who wanted to make an Alien sequel that would have brought Weaver back as Ripley was Walter Hill, who has been a producer on every Alien movie (and got writing credits on Aliens and Alien 3). Hill wrote a 50-page Alien 5 treatment with fellow franchise producer David Giler, who has since passed away, but somehow it didn’t gain any traction. So by getting his Alien movie into production, Alvarez has beaten competition from the likes of Ridley Scott, Neill Blomkamp, and Walter Hill.

aline romulus

THE PITCH STUCK WITH RIDLEY SCOTT

We may not know exactly what Alvarez’s story is, but we do know the pitch made an impact on Ridley Scott, who is producing the movie that could be called Alien: Romulus. Apparently Alvarez told Scott his idea for how to approach a new Alien movie years ago and it was stuck with him. In 2021, Scott called Alvarez and asked him if he was still willing to make that Alien movie. Obviously he was. 20th Century Studios president Steve Asbell had said that they decided to move forward with the project “purely off the strength of Fede’s pitch”, as it’s “just a really good story with a bunch of characters you haven’t seen before.”

Aliens

NO CONNECTION TO OTHER ALIEN FILMS

Sources say that the script Alvarez has written with his frequent collaborator Rodo Sayagues doesn’t have any connection to the previous Alien movies – except, of course, for the presence of the Xenomorph. So we shouldn’t expect to see any tie-ins with the Scott prequels, the adventures of Ripley, or the Predator crossovers. However, doesn’t the story about a distant colony being stricken with a Xenomorph problem sound a lot like what happened on LV-426 before Ripley and the Colonial Marines showed up in Aliens? This is only speculation, but Alvarez could be cooking up a surprise “mid-quel” that takes place within the timeframe of Aliens. The story of the downfall of LV-426. But, maybe it really is a completely different colony. Maybe the sources aren’t trying to throw us off the trail and the movie really doesn’t have any connection to previous installments.

Prey

THEATRICAL RELEASE

Unlike last year’s new Predator movie Prey, the new Alien movie is going to be released theatrically, with the Mouse House giving the film an August 16, 2024 date. This is similar to what the studio did with Barbarian, which grossed $45 million on a $4.5 million budget, and their recent The Boogeyman, which has already raked in $25 million and counting. Many think Prey would have been a blockbuster had it gotten a theatrical release, as people still prefer to see their scary movies in a dark theater. As anyone who’s ever watched an Alien film theatrically can tell you, that’s always the best way.

TV SERIES

While the movie may be hitting theaters, we’ll still be getting some xenomorph content on Hulu, with Noah Hawley’s (Fargo) Alien TV series having recently cast its lead, Sydney Chandler. That show is set on Earth, with FX CEO John Landgraf teasing that the series takes place about seventy years from now, and will not feature any characters from the movies. However, the infamous Weylan-Yutani corporation will still be involved. Currently, the show has no release date and likely will only premiere after the new Alien movie comes out.

Are you looking forward to watching a new Alien movie that leans into pure horror territory as Fede Alvarez sets the Xenomorph lose on a group of young colony residents? Share your thoughts on this project by leaving a comment below.

Originally published at https://www.joblo.com/everything-we-know-about-fede-alvarezs-new-alien-movie/

Fixed: Idris Elba, Adam Devine, Kathryn Hahn lead voice cast for R-rated Genndy Tartakovsky movie

0
Fixed: Idris Elba, Adam Devine, Kathryn Hahn lead voice cast for R-rated Genndy Tartakovsky movie

Idris Elba, Kathryn Hahn, and Adam Devine lead the voice cast for Fixed, an animated R-rated comedy from Genndy Tartakovsky.

Genndy Tartakovsky, the man behind Hotel Transylvania, Star Wars: Clone Wars, Dexter’s Laboratory, Primal, and Samurai Jack, is in the midst of production on Fixed, an R-rated animated comedy that has landed a great voice cast. Variety reports that Adam Devine, Idris Elba, and Kathryn Hahn will be leading the project for New Line Cinema and Sony Pictures Animation.

Fixed revolves around Bull, “an average dog who discovers he’s going to be neutered in the morning. As the gravity of this life-altering event sets in, Bull realizes he needs one last adventure with his pack of best friends as these are the last 24 hours with his balls.” Genndy Tartakovsky told Variety that “some people might get uncomfortable,” but added that “if you can look past the balls and the buttholes, you will find a very sweet, charming, sincere story of friendship and romance.

Adam Devine will voice Bull, with Idris Elba voicing his buddy Rocco and Kathryn Hahn voicing Bull’s love interest Honey. Producer Michelle Murdocca said, “When Kathryn decided to do it, she told us: ‘I want to be just like the guys. I don’t want to be the sweet girl in the background who doesn’t have any depth to her. Make her a little raunchier.’ Hiring her made this character come alive.” The rest of the cast includes Bobby Moynihan as Lucky, Fred Armisen as Fetch, Beck Bennett as Sterling, River Gallo as Frankie, and Michelle Buteau as Molasses. “I have been doing this for 30 years and when you find someone who knows comedic timing as a voice actor, it’s everything. It makes our job so much easier,” Tartakovsky said.

In a world full of elaborate 3D animated movies, Fixed will be proudly 2D. Genndy Tartakovsky called Fixed a love letter to Bugs Bunny, Tex Avery, and 1950s Disney movies, adding that they were “able to secure animators we never thought we would be able to get. That’s when it became very exciting.” Although Tartakovsky has dipped his toe in adult animation before, he has spent most of his career doing television for a younger audience. For those projects, he could never cross a boundary, but for Fixed, “everything had to be over that boundary.” No matter how raunchy Fixed may be, Tartakovsky just wants to make the audience laugh. “Comedy is the hardest thing, always, but in animation, you create it from nothing,” he said. “It’s why I got into it. I could draw a little stick figure running, my friends would look over my shoulder and laugh. It’s such an amazing illusion.

Originally published at https://www.joblo.com/genndy-tartakovsky-fixed-voice-cast/

Deadpool 3: Zazie Beetz confirms she won’t be back for sequel

0
Deadpool 3: Zazie Beetz confirms she won’t be back for sequel

Zazie Beetz confirms that she won’t be reprising her role of Domino for Deadpool 3, but is excited to watch it.

Deadpool 3 will feature the return of a number of actors from the previous movies, but Zazie Beetz won’t be one of them.

While speaking with Decider at the Tribeca Film Festival premiere of her limited-series Full Circle, Zazie Beetz was asked if the ongoing WGA strike was affecting Ryan Reynolds’ ability to improvise on the Deadpool 3 set. “Well I’m actually not in Deadpool 3, so I don’t know what they’re doing [about improvisation],” Beetz said. “I’m assuming they’re probably taking a pause. […] I’m excited to watch it.” Beetz played Domino in Deadpool 2, a mutant mercenary with the ability to manipulate luck.

While the WGA strike has prompted many movies and TV shows to hit pause while a deal between screenwriters and the studios can be worked out, Deadpool 3 is apparently still trucking ahead. As Ryan Reynolds is a credited writer on the film, this has led some to report that the actor won’t “legally” be able to improvise on the film. I guess that’s what reshoots and ADR are for.

Although Zazie Beetz may not be back for Deadpool 3, the sequel will see the return of Morena Baccarin as Vanessa, Leslie Uggams as Blind Al, Karan Soni as Dopinder, Brianna Hildebrand as Negasonic Teenage Warhead, Shioli Kutsuna as Yukio, Stefan Kapičić as the voice of Colossus, and Rob Delaney as Peter.

Of course, the biggest addition to the cast is Hugh Jackman as Wolverine, who finally broke down after being pestered by Ryan Reynolds for so many years. Reynolds recently said that Deadpool 3 will present a new challenge for Jackman. “I think [Jackman] was excited and what we pitched him was enough of a divergence from the character that he knows and the character that he’s left behind,” Reynolds said, “that it gives him something completely new to play and something that he’s really excited to do.” Clearly, all that pestering paid off. “I mean, I never stopped,” Reynolds said. “I was just pestering him like a gnat over the last many years. I actually just think… I believe in timing … and I think he was ready.

Deadpool 3 was originally set to hit theaters on November 8, 2024, but Disney recently bumped the movie up to a May 3, 2024 release. As nearly every other movie on Disney’s slate was pushed back, sometimes by years, it was interesting to see the Deadpool sequel move up.

Originally published at https://www.joblo.com/deadpool-3-zazie-beetz-update/